Defective VHL protein is also present in most cases of advanced clear cell renal cell carcinoma (RCC), so a recommendation ...

The committee also recommended conditional approval of the drug for the treatment of adult patients with advanced clear cell ...

Weill Cornell Medicine has received a $1.4 million, four-year grant from the U.S. Department of Defense to investigate a new therapeutic approach for the most common form of kidney cancer.

Weill Cornell Medicine has received a four-year, $1.4 million grant from the U.S. Department of Defense to investigate a new therapeutic approach for ...

Phase 1 results support further evaluation of ALLO-316 in patients with CD70-positive clear cell renal cell carcinoma, according to researchers.